Orgenesis Delivers Poster Presentation at European Society of Gene and Cell Therapy (ESGCT) Congress

GERMANTOWN, MD -- (Marketwired) -- 09/18/15 -- Orgenesis Inc. (OTCQB: ORGS), a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient''s own cells into functioning insulin-producing cells as a treatment for diabetes, today announced it w ...